Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Ergomed Plc LSE:ERGO London Ordinary Share GB00BN7ZCY67 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  52.00 4.67% 1,166.00 1,162.00 1,166.00 1,176.00 1,114.00 1,114.00 74,620 16:29:56
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 86.4 12.6 20.0 58.3 577

Ergomed Share Discussion Threads

Showing 801 to 824 of 1025 messages
Chat Pages: 41  40  39  38  37  36  35  34  33  32  31  30  Older
DateSubjectAuthorDiscuss
09/12/2020
15:00
IHMMs It's the way it is fella. The one that got away though not done do badly recently so can't complain. Hope it continues to deliver for u
mirabeau
09/12/2020
14:52
Mirabeau - as I said previously - sorry to hear you didn’t get on board but the key was when Barfield joined the co.
ihatemms
09/12/2020
14:49
That's £10 gone. Even though I set up the thread I have never held these. :(
mirabeau
09/12/2020
14:47
Don’t ya just love this share 😎. Glad I topped up with even more recently to add to my already over-weight holding.
ihatemms
07/12/2020
08:15
Thanks Ayl30 "Midas verdict: At £9.30, Ergomed shares have done well this year, benefiting from increased investor interest in almost all healthcare stocks. However, the company is profitable, its balance sheet is robust and the shares should continue to rise as Reljanovic and Barfield roll out their strategy. Buy." (clickable version of your link: hTTps://www.thisismoney.co.uk/money/investing/article-9021145/MIDAS-SHARE-TIPS-Ergomed-leader-drugs-testing-field.html )
grabster
06/12/2020
22:01
Excellent article and good to see just a brief explanation of pharmacovigilance - amazing how many people think that all monitoring and analysis ends once a new drug is approved. This also is pretty impressive - well done to those involved:- 'The group was involved in one of the very first studies (Covid-19), in Italy in March, when employees worked round the clock so the trial could start just eight days after they were appointed to do it.'
bermudashorts
06/12/2020
13:01
https://www.thisismoney.co.uk/money/investing/article-9021145/MIDAS-SHARE-TIPS-Ergomed-leader-drugs-testing-field.html
ayl30
06/12/2020
12:34
That's £10 smashed on Monday then not a holder
mirabeau
03/12/2020
16:09
PrimeVigilance@PrimeVigilance PrimeVigilance is expanding into Japan! We have opportunities for an Associate Director, Pharmacovigilance, Medical Information Officers and Pharmacovigilance Officers. Please contact Sarah at sarah.adams@ergomedplc.com for more information. - better than watching the SP
piedro
01/12/2020
12:30
above 900p being paid
mfhmfh
01/12/2020
10:04
going great guns here. pity i'm not a holder
mirabeau
01/12/2020
10:01
I think we are looking at nearer 920p today. My projection for the year end results is1250p
bramble13
01/12/2020
08:26
900p on the cards today fingers crossed. Someone is mopping up all the available stock.
blueflame
30/11/2020
16:56
678k. Now that is a huge trade in this stock. Bodes well going forward I hope.
blueflame
30/11/2020
16:54
Massive uncrossing trade @ £8.78!
ihatemms
25/11/2020
11:51
Ready to break out in the very near future ....today!!
bramble13
17/11/2020
12:47
There are many talking points in our recent newsletter sent out to members, including our recent webinar with Ergomed. More details on our newsletters can be found here: hTTps://www.sharesoc.org/news/newsletter/
sharesoc
17/11/2020
11:49
Another excellent presentation. Strong sales and contracted backlog trends continued and continuing into Q3 and Q4 with even higher margins as the sales mix changes.
ihatemms
17/11/2020
11:32
Presentation today (11am+)
grabster
12/11/2020
10:27
Why the very short spread today , are they all sales..Interesting !
bramble13
12/11/2020
09:41
Clearly you have not read my earlier post pal - if you did you would think twice about your capital letters. Good luck.
tongosti
12/11/2020
06:32
Cast your mind back to update on the 21st July 2020.Reports "EXCELLENT FIRST HALF " It now expects EBITDA for the year ending 31st December to be "MATERIALLY AHEAD " of current market expectations.Price today now at 790p ....is that materially ahead ..I DON'T THINK SO...DO YOU???Happy investing.
bramble13
10/11/2020
14:13
there is no shame in making a mistake only in not rectifying it. Well I did a mistake reinitiating yesterday and just covered the whole lot. -8% on the trade (translating into a -0.6% at account level) but never happy to give a suspicious trade the benefit of the doubt. Always live to trade another day folks.
tongosti
09/11/2020
09:29
Get in there!
germanbanker
Chat Pages: 41  40  39  38  37  36  35  34  33  32  31  30  Older
ADVFN Advertorial
Your Recent History
LSE
ERGO
Ergomed
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221003 04:47:46